Fact CheckerSign in

NCT05318482Completed

Motivational Program on Physical Activity in Cardio-respiratory Patients: an RCT Study

Effects of Physical Activity of an In-hospital Motivational Program in Cardio-respiratory Patients: a Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 7 Nov 2024

Brief summary (registry, in English)

According to actual scientific evidence, the interventions on the general population aiming at regular physical activity are one of the most efficient strategies for health improvement. Regardless of this evidence, there is a large part of the elderly population does not adhere to the recommendations of the international guidelines on daily physical activity. This is even more evident in patients with chronic respiratory and cardiological disease because exercise exacerbates existing symptoms of breathlessness. This study aims to evaluate the impact of an in-hospital motivational program dedicated to increasing physical activity. With the data of an electronic wristwatch that keeps records of movement, the health professionals incentive an increase in physical activity leading to long term behavioural changes (evaluated by the number of steps per day) in hospitalized patients with COPD and HF, which already perform a standard rehabilitation program (14 sessions).

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
30 Mar 2022
Start date
23 Mar 2022
Primary completion date
1 Jun 2024
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
NCT number
NCT05318482

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 23 Mar 2022 to the primary completion date, 1 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant symptoms of the primary disorder, not properly stabilized;
  • Clinical signs of cognitive impairment (MMSE \< 25).

Other

  • Hemodynamic and clinic instability;
  • Musculoskeletal issues or other types (neurological, orthopedical…), which involve an important limitation in physical exercise performance;
  • Medical comorbidities with a life expectancy shorter than one year;

Who the study is looking for

  • \>18 years, both of genders;
  • Scheduled time of hospitalization of at least 14-16 days;
  • Ability to walk by themselves, with safety (SPPB \>10);
  • Hospital admission with a diagnosis of COPD (GOLD III-IV, B-D), with or without respiratory failure, or HF (NYHA II-III), sufficiently stabilized with a specific pharmacological therapy
  • Possession of a smartphone and ability to use the app for health tracking.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituti Clinici Scientifici Maugeri IRCCS
Coordinator of this site? Confirm its status
LumezzaneItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.